Localization Analysis of Heterophilic Antigen Epitopes of H1N1 Influenza Virus Hemagglutinin.


Journal

Virologica Sinica
ISSN: 1995-820X
Titre abrégé: Virol Sin
Pays: Netherlands
ID NLM: 101514185

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 27 08 2018
accepted: 23 01 2019
pubmed: 26 4 2019
medline: 14 8 2019
entrez: 26 4 2019
Statut: ppublish

Résumé

Previous studies have indicated that two monoclonal antibodies (mAbs; A1-10 and H1-84) of the hemagglutinin (HA) antigen on the H1N1 influenza virus cross-react with human brain tissue. It has been proposed that there are heterophilic epitopes between the HA protein and human brain tissue (Guo et al. in Immunobiology 220:941-946, 2015). However, characterisation of the two mAbs recognising the heterophilic epitope on HA has not yet been performed. In the present study, the common antigens of influenza virus HA were confirmed using indirect enzyme-linked immunosorbent assays and analysed with DNAMAN software. The epitopes were localized to nine peptides in the influenza virus HA sequence and the distribution of the peptides in the three-dimensional structure of HA was determined using PyMOL software. Key amino acids and variable sequences of the antibodies were identified using abYsis software. The results demonstrated that there were a number of common antigens among the five influenza viruses studied that were recognised by the mAbs. One of the peptides, P2 (LVLWGIHHP

Identifiants

pubmed: 31020574
doi: 10.1007/s12250-019-00100-9
pii: 10.1007/s12250-019-00100-9
pmc: PMC6599510
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antibodies, Viral 0
Antigens, Heterophile 0
Antigens, Viral 0
Epitopes 0
H1N1 virus hemagglutinin 0
Hemagglutinin Glycoproteins, Influenza Virus 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Pagination

306-314

Références

J Immunol. 2000 Dec 15;165(12):6949-55
pubmed: 11120821
J Mol Recognit. 2001 Mar-Apr;14(2):110-21
pubmed: 11301481
J Immunol. 2002 Mar 1;168(5):2371-82
pubmed: 11859128
FASEB J. 2002 May;16(7):642-52
pubmed: 11978728
Nat Med. 2002 May;8(5):509-13
pubmed: 11984596
PLoS One. 2010 Jul 12;5(7):e11548
pubmed: 20634959
PLoS One. 2011 Mar 18;6(3):e18016
pubmed: 21437206
J Clin Virol. 2011 Jun;51(2):146-7
pubmed: 21450518
Vaccine. 2011 Jul 12;29(31):4897-902
pubmed: 21596084
Pediatr Neurol. 2012 Jul;47(1):51-4
pubmed: 22704018
J Pathol. 2013 May;230(1):1-3
pubmed: 23389883
Semin Respir Crit Care Med. 2013 Aug;34(4):475-86
pubmed: 23934716
Clin Exp Immunol. 2014 Feb;175(2):192-201
pubmed: 24128311
PLoS One. 2013 Nov 05;8(11):e79628
pubmed: 24223983
Clin Infect Dis. 2014 Apr;58(8):1149-55
pubmed: 24415636
Pediatr Neurol. 2014 Sep;51(3):370-6
pubmed: 25160541
Neuropediatrics. 2015 Feb;46(1):20-5
pubmed: 25290723
Immunobiology. 2015 Aug;220(8):941-6
pubmed: 25708705
Sci Transl Med. 2015 Jul 1;7(294):294ra105
pubmed: 26136476
Immunol Lett. 2016 Apr;172:11-20
pubmed: 26875772
Sci Rep. 2016 Nov 08;6:36629
pubmed: 27824133
J Mol Biol. 2017 Mar 24;429(6):836-846
pubmed: 28189425
Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6107-E6116
pubmed: 28696309
Sleep Med Rev. 2018 Apr;38:177-186
pubmed: 28847694
Int J Mol Med. 2018 Mar;41(3):1673-1682
pubmed: 29286160
J Infect Dis. 2018 Mar 28;217(8):1237-1246
pubmed: 29329410
J Virol. 1986 Jan;57(1):397-401
pubmed: 3753614
Pediatrics. 1982 Dec;70(6):895-900
pubmed: 7145544

Auteurs

Chun-Yan Guo (CY)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Hai-Xiang Zhang (HX)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Jun-Jun Zhang (JJ)

Xian Yang Municipal Center for Disease Control and Prevention, Xianyang, 712000, China.

Li-Jun Sun (LJ)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Hui-Jin Li (HJ)

Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, 710021, China.

Dao-Yan Liang (DY)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Qing Feng (Q)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Yan Li (Y)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Yang-Meng Feng (YM)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Xin Xie (X)

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi'an, 710069, China. xiexin@nwu.edu.cn.

Jun Hu (J)

Shaanxi Province Research Center of Cell Immunological Engineering and Technology, Central Laboratory of Shaanxi Provincial People's Hospital, Xi'an, 710068, China. hjj65622@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH